Hta

HTA Antihipertensivo de elección según el perfil del paciente Sara Conde-Valvís Fraga R3 MFyC Julio 2011

Introducción ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Diagnóstico >110 >180 HTA GRAVE/3 >120 >180 >210 CRISIS HTA Eu SocEspHTA >80 >120 PA NORMAL >90 >140 HTA LIGERA/1 >100 >160 HTA MOD/2 >85 >130 PA N-ALTA <80 <120 PA OPTIMA

Estratificación RCV ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Bases tratamiento ,[object Object],[object Object],[object Object],[object Object]

Hechos ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Recomendaciones ,[object Object],[object Object],[object Object],[object Object]

Objetivo tratamiento antiHTA <130/80 ,[object Object],<140/90 ,[object Object],<130/80 ,[object Object],<135/85 ,[object Object],<125/75 ,[object Object],<120/80 ,[object Object]

Medidas no farmacológicas ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Medidas farmacológicas ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Normas eleccíón antiHTA ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Indicaciones ,[object Object],[object Object],[object Object],[object Object],[object Object],ARAII CA IECA D BB X X X X X X X X X

[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],X X X X No dihid X X X X X X ARAII CA IECA D BB X X X ASA X X X X X X X

[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],X X X ARAII CA IECA D BB X X X X X X X X

Contraindicaciones ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Estrategia inicial del tratamiento antiHTA en función RCV global

Incumplimiento terapéutico ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Estrategias ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Bibliografía ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Hta

Recomendados

Recomendados

Más contenido relacionado

La actualidad más candente

La actualidad más candente (20)

Destacado

Destacado (8)

Similar a Hta

Similar a Hta (20)

Más de Hospital Guadix

Más de Hospital Guadix (20)

Último

Último (20)

Hta

Notas del editor